PRL-3 expression enhances the invasion and proliferation of glioma cells, highlighting this phosphatase as a novel prognostic candidate and an attractive target for future therapy in glioblastoma.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: